Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cardiac Science Completes Private Placement.


IRVINE, Calif.--(BW HealthWire)--Sept. 2, 1997--Cardiac Science Inc. (OTC/BB:DFIB) announced the closing of a $1.5 million private placement of its common stock at $.175 per share (on a pre-reverse stock split basis).

The placement was administered by Sorbus Asset Strategies S.A. of Zurich, Switzerland. In connection with the financing the company is effectuating, as of Sept. 8, a reverse stock split of one-for-11.43, which will reduce the number of shares of common stock outstanding on a fully diluted basis to 5,924,453 shares. This measure was approved by the company's shareholders at a special meeting of the shareholders held May 15.

"The proceeds from this financing will enable us to design the Powerheart AECD AECD Automatic external cardioverter-defibrillator A device that monitors cardiac rhythm and automatically defibrillates  (Automatic External Cardioverter Defibrillator defibrillator, device that delivers an electrical shock to the heart in order to stop certain forms of rapid heart rhythm disturbances (arrhythmias). The shock changes a fibrillation to an organized rhythm or changes a very rapid and ineffective cardiac rhythm to a ) for production and begin manufacturing it for sale in selected European countries, thus allowing the company to generate revenue while it awaits 510(k) approval from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 to market the device in the U.S.," said Raymond W. Cohen cohen
 or kohen

(Hebrew: “priest”) Jewish priest descended from Zadok (a descendant of Aaron), priest at the First Temple of Jerusalem. The biblical priesthood was hereditary and male.
, president and chief executive officer of Cardiac Science. "In addition, the financing has exposed Cardiac Science to the international investment community."

Cardiac Science developed the Powerheart Automatic External Cardioverter Defibrillator (AECD), a non-invasive hospital bedside device that monitors and detects life-threatening heart rhythms and automatically administers a defibrillation Defibrillation Definition

Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm.
 shock without human intervention should a patient suffer cardiac arrest cardiac arrest
n.
Abbr. CA A sudden cessation of cardiac function, resulting in loss of effective circulation.


Cardiac arrest
A condition in which the heart stops functioning.
.

Cardiac Science also manufactures PC-based Holter ECG ECG electrocardiogram.

ECG
abbr.
1. electrocardiogram

2. electrocardiograph


ECG
Also called an electrocardiogram, it records the electrical activity of the heart.
 systems and Holter recorders and distributes these products in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and in more than 40 international countries through its subsidiary, Diagnostic Monitoring. For more information, visit the Cardiac Science Web site at www.cardiacscience.com -0- NOTE: This news release contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, which involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors affecting the company's operations, markets, products, services and prices, and other factors. The company's actual results could differ materially from those projected in the forward-looking statements as a result of the factors described herein.

CONTACT: Cardiac Science Inc., Irvine

Raymond W. Cohen, 714/587-0357

or

Financial Sciences of America

Fran Daniels, 310/278-4413
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 2, 1997
Words:364
Previous Article:Merisel Noteholders Extend Agreement to Sept. 18, Continue Discussions to Improve Debt Restructuring; Stonington Submits Amended Proposal.
Next Article:Equity Inns to Acquire Two Hotels in Separate Transactions for $42 Million.
Topics:



Related Articles
Cardiac Science Inc. acquires Diagnostic Monitoring.
Cardiac Science Announces First Quarter Results.
CardioDynamics International Corporation Announces $6,000,000 Equity Private Placement.
Cardiac Science Contracts With ZEVEX to Manufacture Its Automatic Bedside Defibrillator-monitor.
Cardiac Pathways Names Eldon M. Bullington Chief Financial Officer and Sandra Miller Vice President of Operations.
Cardiac Pathways Granted Patent Related to Its Realtime Position Management Tracking System.
"Heart rhythm" & "J. of the American College of Radiology".
SHCA starts work on new hospital laboratory.
Cardiac perforation and tamponade: a potentially fatal complication during transjugular intrahepatic portosystemic shunt placement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles